Publications by authors named "Philipp Novak"

Claim this Profile
R
Retraction Note: Cerebrolysin™ efficacy in a transgenic model of tauopathy: role in regulation of mitochondrial structure.
Edward Rockenstein, Kiren Ubhi, Margarita Trejo, Michael Mante, Christina Patrick, Philipp Novak

BMC Neurosci· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebrolysin™ efficacy in a transgenic model of tauopathy: role in regulation of mitochondrial structure.
Edward Rockenstein, Kiren Ubhi, Margarita Trejo, Michael Mante, Christina Patrick, Philipp Novak

BMC Neurosci· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regional comparison of the neurogenic effects of CNTF-derived peptides and cerebrolysin in AβPP transgenic mice.
Edward Rockenstein, Kiren Ubhi, Edith Doppler, Philipp Novak, Herbert Moessler

J Alzheimers Dis· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beneficial effects of a neurotrophic peptidergic mixture persist for a prolonged period following treatment interruption in a transgenic model of Alzheimer's disease.
Edward Rockenstein, Kiren Ubhi, Emiley Pham, Sarah Michael, Edith Doppler, Philipp Novak

J Neurosci Res· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebrolysin in vascular dementia: improvement of clinical outcome in a randomized, double-blind, placebo-controlled multicenter trial.
Alla B Guekht, Herbert Moessler, Philipp H Novak, Evgenyi I Gusev,

J Stroke Cerebrovasc Dis· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurotrophic factor treatment of neurological disorders: the benefits of a pleiotropic treatment approach. Commentary.
Dafin F Muresanu, Edith Doppler, Philipp Novak

CNS Neurol Disord Drug Targets· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence of the effects of Cerebrolysin on cognition and qEEG slowing in vascular dementia patients: results of a 3-month extension study.
Dafin F Muresanu, X Anton Alvarez, Herbert Moessler, Philipp H Novak, Adina Stan

J Neurol Sci· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of Cerebrolysin in patients with hemorrhagic stroke.
O Bajenaru, C Tiu, H Moessler, F Antochi, D Muresanu, Philipp Novak

J Med Life· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute drug prescribing to children on chronic antiepilepsy therapy and the potential for adverse drug interactions in primary care.
Philipp H Novak, Suzie Ekins-Daukes, Colin R Simpson, Robert M Milne, Peter Helms

Br J Clin Pharmacol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis